University of Pittsburgh - of The Commonwealth System of Higher Education;National Research Council of Canada
发明人:
HINCK, Andrew, Peterson,SULEA, Traian
申请号：
EP17871472
公开号：
EP3541409A4
申请日:
2017.11.17
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Recombinant transforming growth factor (TGF)-β monomers modified to inhibit dimerization and block TGF-β signaling are described. The recombinant TGF-β monomers lack the ability to bind and recruit TGF-β type I receptor (TβR1), but retain the capacity to bind the high affinity TGF-β type II receptor (TβRII), and in some instances, include mutations that increase their affinity for TβRII. Nucleic acid molecules and vectors encoding the recombinant TGF-β monomers are also described. Isolated cells, such as T cells, can be re-programmed with a TGF-β monomer-encoding nucleic acid or vector to secrete the monomer. Use of the recombinant TGF-β monomers and/or cells producing the recombinant TGF-β monomers, to inhibit TGF-β signaling, such as to treat disorders associated with aberrant TGF-β signaling, are also described.
